Solabia Group has acquired Algatech Ltd. for an undisclosed sum.
Photo © iStockphoto.com/skynesher
Solabia Group (Paris, France) has acquired Algatech Ltd. (Harrison, NY) for an undisclosed sum. A leader in microalgae, Algatech has experienced high double-digit top line growth over the last several years, a trajectory it hopes to continue with Solabia’s backing. The strategic investment will support Algatech’s research and development (R&D) efforts, as well as the expansion of its production capabilities to meet the increasing global demand for microalgae products.
“Algatech’s pioneering R&D, impressing manufacturing facilities, market leading product portfolio, and established customer base brings the opportunity for Solabia to be present in both fields of macroalgae and microalgae whose futures are very promising,” said Gerard Josset, CEO of Solabia Group, in a press release.
“Together with Solabia, we are poised to extend the Algatech growth story as part of our larger organization with extensive global footprint, a shared commitment to innovation, research and development, and an unwavering focus on utilizing the benefits of microalgae to elevate the health of all of us,” said Hagai Stadler, CEO of Algatech, in a press release. “I am thankful for the hard work and dedication of our employees, and the incredible support of our previous investors Grovepoint Capital and JCA Charitable Foundation over the past six years.”
The transaction represents a full realization of Grovepoint Capital’s and JCA Charitable Foundation’s investments, while Kibbutze Ketura, where Algatech's operation is based out of, will retain a minority share of Algatech.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.